UK markets closed

AbbVie Inc. (0QCV.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
146.95-0.42 (-0.28%)
At close: 07:14PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.68
52-week change 3N/A
S&P500 52-week change 3-4.45%
52-week high 3147.40
52-week low 3146.93
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.5B
Implied shares outstanding 6N/A
Float 81.77B
% held by insiders 10.11%
% held by institutions 171.89%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 35.53
Trailing annual dividend yield 33.75%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin 22.03%
Operating margin (ttm)33.06%

Management effectiveness

Return on assets (ttm)8.14%
Return on equity (ttm)92.71%

Income statement

Revenue (ttm)57.35B
Revenue per share (ttm)32.39
Quarterly revenue growth (yoy)4.50%
Gross profit (ttm)38.88B
EBITDA 27.17B
Net income avi to common (ttm)12.57B
Diluted EPS (ttm)6.97
Quarterly earnings growth (yoy)20.60%

Balance sheet

Total cash (mrq)9.96B
Total cash per share (mrq)5.64
Total debt (mrq)73.19B
Total debt/equity (mrq)498.28
Current ratio (mrq)0.84
Book value per share (mrq)8.29

Cash flow statement

Operating cash flow (ttm)22.92B
Levered free cash flow (ttm)18.63B